We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MESO
3351
Mesoblast
MESO
$1.99B
| $141K | ﹤0.01% |
+12,964
| New | +$145K |
|
3352
AbCellera Biologics
ABCL
$1.62B
| $141K | ﹤0.01% |
41,003
+2,656
| +7% | +$6.61K |
|
3353
Mama's Creations
MAMA
$825M
| $141K | ﹤0.01% |
+16,930
| New | +$122K |
|
3354
Sana Biotechnology
SANA
$885M
| $140K | ﹤0.01% |
51,458
-13,342
| -21% | -$27.5K |
|
|
BKN
3355
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $140K | ﹤0.01% |
12,799
| – | – |
|
3356
Theravance Biopharma
TBPH
$874M
| $139K | ﹤0.01% |
+12,608
| New | +$123K |
|
3357
Dyne Therapeutics
DYN
$4.04B
| $138K | ﹤0.01% |
14,541
+2,797
| +24% | +$30.8K |
|
3358
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
| $138K | ﹤0.01% |
15,520
-23,576
| -60% | -$198K |
|
|
ETNB
3359
DELISTED
89bio
ETNB
| $137K | ﹤0.01% |
+13,914
| New | +$115K |
|
|
NGD
3360
DELISTED
New Gold Inc
NGD
| $136K | ﹤0.01% |
27,575
+2,071
| +8% | +$8.51K |
|
3361
Porch Group
PRCH
$1.3B
| $136K | ﹤0.01% |
+11,550
| New | +$99.2K |
|
|
SVM
3362
Silvercorp Metals
SVM
$2.13B
| $136K | ﹤0.01% |
32,224
+1,149
| +4% | +$4.45K |
|
|
NOAH
3363
Noah Holdings
NOAH
$588M
| $135K | ﹤0.01% |
11,321
-5,156
| -31% | -$52K |
|
3364
Xperi
XPER
$365M
| $135K | ﹤0.01% |
+17,050
| New | +$129K |
|
3365
Capricor Therapeutics
CAPR
$1.14B
| $135K | ﹤0.01% |
13,557
+271
| +2% | +$2.86K |
|
3366
Priority Technology Holdings
PRTH
$518M
| $134K | ﹤0.01% |
+17,276
| New | +$130K |
|
|
PPTA
3367
Perpetua Resources
PPTA
$2.23B
| $134K | ﹤0.01% |
+11,035
| New | +$149K |
|
3368
Precigen
PGEN
$1.93B
| $134K | ﹤0.01% |
94,291
+52,901
| +128% | +$75.2K |
|
3369
Playtika
PLTK
$1.4B
| $133K | ﹤0.01% |
28,089
+16,546
| +143% | +$81.4K |
|
|
LAC
3370
Lithium Americas
LAC
$986M
| $131K | ﹤0.01% |
48,936
+7,610
| +18% | +$21.1K |
|
3371
Iovance Biotherapeutics
IOVA
$2.23B
| $131K | ﹤0.01% |
75,994
+10,806
| +17% | +$26.9K |
|
3372
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.57B
| $130K | ﹤0.01% |
12,025
-1
| -0% | -$5 |
|
3373
Melco Resorts & Entertainment
MLCO
$2.1B
| $130K | ﹤0.01% |
17,981
+7,239
| +67% | +$42.1K |
|
3374
Organogenesis Holdings
ORGO
$308M
| $130K | ﹤0.01% |
35,392
+16,205
| +84% | +$60.4K |
|
|
GRFS
3375
Grifois
GRFS
$5.16B
| $129K | ﹤0.01% |
14,273
-515
| -3% | -$4.02K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.